CUL4A and breast cancer: The significance of CUL4A in chemoresistance is further exemplified by analyzing public breast cancer datasets, revealing that a high tumor CUL4A expression correlates to low survival in breast cancer patients treated with chemotherapy, but not in those without chemotherapy (Figure 6), implying that CUL4A is involved in cell sensitivity to chemotherapeutic agents.